Actively Recruiting
Evaluation of IGRA, Symptoms and Chest Radiograph for Subclinical TB Detection in ESRD and KT
Led by Mahidol University · Updated on 2024-11-22
160
Participants Needed
1
Research Sites
151 weeks
Total Duration
On this page
Sponsors
M
Mahidol University
Lead Sponsor
N
National Research Council of Thailand
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is an observational study among approximately 160 end-stage renal disease patients on renal replacement therapy and post-living donor or deceased donor kidney transplant recipients. Investigators aim to assess the proportion of positive IGRA associated with symptom development, sputum Xpert MTB/RIF assay, and chest radiograph to define latent TB infection and subclinical TB among ESKD and renal transplant patients.
CONDITIONS
Official Title
Evaluation of IGRA, Symptoms and Chest Radiograph for Subclinical TB Detection in ESRD and KT
Who Can Participate
Eligibility Criteria
You may qualify if you...
- End-stage renal disease on renal replacement therapy (hemodialysis or peritoneal dialysis) or status-post-living donor or deceased donor kidney transplantation
- Aged more than or equal 18 years
You will not qualify if you...
- Positive PPD test or a previously documented positive PPD
- Active pulmonary or extrapulmonary tuberculosis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University
Bangkok, Thailand, 10400
Actively Recruiting
Research Team
T
Tanaya Siripoon, M.D.
CONTACT
P
Punnee Pitisuttithum, Prof. E.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here